KNTK Kinetik Holdings Inc. Insider Trading

ISQ Global Fund II sells ~534k shares of Kinetik Holdings, trimming ~65% of stake; institutional portfolio rebalancing amid recent rally.

ISQ Global Fund II, a major institutional holder, liquidated roughly two-thirds of its Kinetik position across three sales, generating approximately $27 million in proceeds. This is institutional portfolio management, not insider conviction—the fund's track record on prior exits shows mixed timing, with recent stock declines following similar sales, yet no clear pattern of foresight. The timing coincides with Kinetik trading just below its recent highs after a notable recovery over the past few months, which may reflect the fund taking profits rather than acting on negative signals about the company's fundamentals. Kinetik itself remains profitable with steady revenue growth and a reasonable valuation, providing no independent reason to view this exit as bearish. Investors should interpret this exit as a fund rebalancing its portfolio exposure to a solid performer, not as a warning sign about the business itself.

10% owner ISQ Global Fund II GP LLC sells ~376K shares across three days for ~$18.5M as stock approaches recent highs.

ISQ Global Fund II GP LLC, a 10% beneficial owner of Kinetik Holdings, conducted a three-day liquidation totaling approximately 376,000 shares worth $18.5 million. This is institutional portfolio management, not insider conviction—the fund is rebalancing its position, not signaling concern about company prospects. The timing is notable: the stock is trading near its recent peak after a strong three-month rally, which often prompts funds to take profits on outperforming positions. Kinetik itself remains a profitable, growing company with solid fundamentals, and there's no indication of deteriorating business conditions behind this sale. For retail investors, this is essentially background noise—large shareholders regularly trim positions for diversification or allocation reasons, especially when valuations have appreciated meaningfully.

10% owner ISQ Global Fund II GP LLC sold 4,000,000 (4.00M shares) of KNTK at $44.85 on 2026-02-26; retains 1 share post-transaction.

ISQ Global Fund II GP LLC, a 10% owner, sold 4,000,000 shares at $44.85 per share for $179,400,000.00 total value, reducing its KNTK position from 4,000,001 to 1 share. This represents a material reduction in a significant ownership stake at a price approximately 4.4% below the current market price of $46.92. The fund's prior four sales at KNTK were all well-timed at the 90-day mark, with post-sale declines ranging from -7.5% to -19.0%, suggesting a consistent pattern of selling ahead of downside price movement at this ticker. While KNTK fundamentals remain reasonable (P/E 17.64, +19.0% annual revenue growth), the magnitude of this derivative-conversion transaction and the seller's historical timing pattern at this security warrant monitoring of whether the market will follow the previous post-sale trajectory.

Welch Jamie bought 8,000 shares of KNTK at $34.57; stock now -48.9% from 52-week high, but insider's prior 4 KNTK buys showed +17.2%, +17.2%, +1.2%, +12.9% at 90 days.

Welch Jamie purchased 8,000 shares (0.2% of post-transaction holdings of 3.69M shares) at $34.57 on 2025-11-10, valued at $276,560.00. The stock has declined sharply—now trading -48.9% from its 52-week high of $66.47 and down -19.0% over 90 days. However, this insider's prior same-ticker history shows a consistent pattern: 4 of 4 measurable prior KNTK buys at this insider delivered 90-day returns of +17.2%, +17.2%, +1.2%, and +12.9%, establishing a 100% win rate at this ticker over the 90-day horizon. The current purchase follows a more recent buy on 2025-10-02 (showing -1.6% at 30 days). The company's fundamentals remain solid with revenue of $464.0M, annual growth of +18.0%, and a P/E of 17.87, suggesting the stock's recent decline may reflect market sentiment rather than operational deterioration.

Executive Jamie Welch purchases 5,000 KNTK shares at $39.13; stock down 42.0% from 52-week high but insider's prior 4 KNTK buys showed 100% 90-day win rate.

Jamie Welch purchased 5,000 shares of Kinetik Holdings at $39.13 on 2025-10-02, increasing holdings to 3,676,399 shares. The purchase occurs amid significant recent weakness: KNTK is -42.0% from its 52-week high of $66.47 and down 7.0% over the past 30 days. However, this insider's prior trading behavior at KNTK warrants close attention—his 4 prior buys at this ticker (most recent on 2024-03-18) demonstrated a 100% 90-day win rate, with gains ranging from +1.2% to +17.2% at the 90-day mark. His cross-ticker track record shows an average 90-day return of +12.1% with a 100.00% win rate across 4 prior open-market buys. The stock's valuation metrics—P/E of 13.21, +18.0% annual revenue growth, and quarterly revenue of $426.7M—remain fundamentally sound. This purchase suggests conviction at depressed levels, though the timing signal depends on whether this transaction reflects continued disciplined accumulation or a reaction to near-term price pressure.

ISQ Global Fund II GP LLC sells 4,262,090 KNTK shares at $44.16; post-transaction 1 share remains.

ISQ Global Fund II GP LLC, a 10% owner, disposed of 4,262,090 shares (4.26M shares) of Kinetik Holdings on 2025-06-04 at $44.16 per share, generating $188,213,894.40 in proceeds. The transaction reduces the fund's common stock holdings to 1 share post-trade, though a FLAG notes that derivative holdings in Form 4 Table II are not yet populated in the database and may represent an offsetting or continued position not visible in Table I alone. At the same-ticker level, this insider's prior three KNTK sales (March 2025) exhibited negative 30-day returns of -16.9%, -17.7%, and -11.6%, with the earliest measurable 90-day outcome at -19.0%, consistent with well-timed exit patterns. The current stock price of $44.07 is 33.7% below the 52-week high of $66.47, reflecting a sharp pullback from peak valuations. Fundamentals remain solid with P/E of 12.77, annual revenue growth of +18.0%, and a market cap of $2,917,434,000.00, suggesting the price decline is not driven by operational deterioration but rather market repricing or sector dynamics.

ISQ Global Fund II GP LLC sells 1,702,101 shares of KNTK for $89,632,638.66 in 2 transactions at $52.66

ISQ Global Fund II GP LLC, a 10% owner, executed 2 separate sales totaling 1,702,101 shares on 2025-03-17 and 2025-03-18 at a blended average price of $52.66, generating $89,632,638.66. The seller holds 1 share post-transaction, representing a -100.0% reduction of its 1,702,102 pre-transaction shares. The current stock price of $54.32 stands -18.3% from the 52-week high of $66.47, suggesting the seller executed these trades at prices above recent market lows but within an elevated range. This transaction must be understood as a conversion of derivative securities (Form 4 Table II), not necessarily a complete position exit—the insider may retain derivative holdings not yet populated in this filing's data. Fundamentals remain solid with revenue of $396,362,000, net income of $265,683,000, and forward-looking 18.0% annual revenue growth, yet the insider chose to sell common shares during a period marked by -11.4% monthly price decline.

10% owner ISQ Global Fund II GP LLC sells 3,952,431 shares of KNTK for $219.9M at $55.63; holdings drop from 5.00M to 1.04M (-79.1%)

ISQ Global Fund II GP LLC, a 10% owner, sold 3,952,431 shares on 2025-03-04 for $219,873,736.53, reducing its stake from 4,996,951 to 1,044,520 shares—a -79.1% reduction in holdings. The sale occurred at $55.63 per share, which was $4.45 above the current market price of $51.18 and near the 52-week high of $66.47. The company's fundamentals remain strong with $396.4M in latest quarterly revenue, $265.7M net income, and an 18.0% annual revenue growth rate at a modest 9.60 P/E ratio. However, stock price action has softened significantly, down 19.2% over 30 days and 23.0% from the 52-week high, which may have motivated the timing of this substantial divestiture by a core shareholder.